drugset / Trial / NCT03468699

Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia

NCT03468699 ↗

NaSingle-groupOpen-labelTreatment

Summary

The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cell transplantation for Children Suffering from Liver Cirrhosis Due to Biliary Atresia

Timeline

Start
2017-01-02
Primary completion
2021-09-30
Completion
2021-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous BMMC transplantation Cell therapy 50.1 cells/kg Other
Subject Autologous BMMC transplantation Cell therapy 57.1 cells/kg Other

Indications